Harris, S T <br/><br/>
Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis.  [electronic resource] 

 -  Current medical research and opinion  May 2004 
 - 757-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0300-7995 
<br/><br/><label>Standard No.: </label>10.1185/030079904125003566  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analysis of Variance<br/>Bone Density--drug effects<br/>Double-Blind Method<br/>Etidronic Acid--administration & dosage<br/>Humans<br/>Lumbar Vertebrae<br/>Male<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Risedronic Acid<br/>Spinal Fractures--prevention & control<br/>Treatment Outcome